Skip to content

Trial for Femoroacetabular Impingement Treatment

A Randomised Controlled Trial of Surgical Versus Non-surgical Treatment of Femoroacetabular Impingement

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01893034
Acronym
FAIT
Enrollment
120
Registered
2013-07-08
Start date
2013-07-31
Completion date
2017-07-31
Last updated
2013-12-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Femoroacetabular Impingement

Keywords

Femoroacetabular Impingement, Arthroscopy, Physiotherapy, Randomised Controlled Trial

Brief summary

Femoroacetabular Impingement (FAI) describes a condition of the hip where additional bone results in the abutment of the femoral neck against the rim of the acetabulum. This gives rise to localised cartilage damage and pain, but also increases the risk of developing osteoarthritis. The purpose of this study is to compare the effectiveness of arthroscopic surgery versus physiotherapy and activity modification for the treatment of this condition.

Interventions

PROCEDUREArthroscopic treatment of femoroacetabular impingement
OTHERPhysiotherapy and activity modification

Sponsors

University of Oxford
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Symptomatic patients * Age 18-60 years * Clinical and radiological evidence of FAI * Competent to consent

Exclusion criteria

* Prior hip surgery * Established osteoarthritis (Kellgren-Lawrence \>/= 2) * Hip dysplasia (Centre-Edge angle \< 20 degrees on radiograph) * Completion of physiotherapy programme targeting FAI within past year * Co-morbidities that mean surgical intervention is not possible/safe * Contraindication to MRI * Pregnancy

Design outcomes

Primary

MeasureTime frameDescription
Hip Outcome Score8 months post randomisation (approximately 6 months post intervention)Hip Outcome Score is a patient reported outcome measure

Secondary

MeasureTime frameDescription
Patient Reported Outcome MeasuresRegular intervals up to 38 months post randomisation (approximately 3 years post intervention)
Morphological and Physiological MRIRegular intervals up to 38 months post randomisation (approximately 3 years post intervention)* Morphological Parameters * Measures of Osteoarthritis
Hip RadiographsRegular intervals up to 38 months post randomisation (approximately 3 years post intervention)* Morphological Parameters * Measures of Osteoarthritis
Serum and Urinary Biomarkers of OsteoarthritisRegular intervals up to 38 months post randomisation (approximately 3 years post intervention)
Clinical ExaminationRegular intervals up to 38 months post randomisation (approximately 3 years post intervention)* Range of Movement * Impingement Tests

Countries

United Kingdom

Contacts

Primary ContactAntony Palmer, MA BMBCh
antony.palmer@ndorms.ox.ac.uk+441865 227374

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026